Facebook Linkedin RSS Twitter Youtube
Home 2024

FDA policy

Modeling Clonal Evolution in Hematopoietic Malignancies
Cancer

Modeling Clonal Evolution in Hematopoietic Malignancies

Rentschler Biopharma’s New Production Line in Massachusetts Now Fully Operational
Bioprocessing

Rentschler Biopharma’s New Production Line in Massachusetts Now Fully Operational

FDA Imposes Partial Hold on BioNTech/MedLink ADC Trial after Three Patient Deaths
Cancer

FDA Imposes Partial Hold on BioNTech/MedLink ADC Trial after Three Patient Deaths

Multiply Labs and Retro Biosciences Partner on Cell Therapy Manufacturing for Age-Related Diseases
Bioprocessing

Multiply Labs and Retro Biosciences Partner on Cell Therapy Manufacturing for Age-Related Diseases

ASGCT 2024: Kate Therapeutics Unveils Gene Therapy Platform and Product Pipeline Progress
Genome Editing

ASGCT 2024: Kate Therapeutics Unveils Gene Therapy Platform and Product Pipeline Progress

FDA Approves Pfizer’s One-Time Gene Therapy BEQVEZ for Hemophilia B
Drug Discovery

FDA Approves Pfizer’s One-Time Gene Therapy BEQVEZ for Hemophilia B

Immunotherapy Safely Boosted with Particle-Bound Cytokines in Tumor Models
Cancer

Immunotherapy Safely Boosted with Particle-Bound Cytokines in Tumor Models

Is Gene Therapy Nearing a Tipping Point?
Drug Discovery

Is Gene Therapy Nearing a Tipping Point?

New FDA Guidance Impacts the CAR-T Industry
Bioprocessing

New FDA Guidance Impacts the CAR-T Industry

Game On for Concussion Therapies
Insights

Game On for Concussion Therapies

123...7Page 1 of 7
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.